NYT Stock Recent News

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

NEW YORK--(BUSINESS WIRE)--The New York Times Company (NYSE: NYT) today announced that it will issue its second-quarter 2025 financial results on Wednesday, August 6, at approximately 7:00 a.m. E.T. by posting the results on the Company's investor relations website at investors.nytco.com. At that time, the Company will issue an advisory release over a newswire service to announce that the results have been posted and are available on the Company's website at investors.nytco.com. The Company's e.

The New York Times is reassigning its pop music, theater, television and classical music critics as part of a plan to bring “new perspectives” to coverage.

CNBC's Deirdre Bosa reports on the artificial intelligence arms race between major tech companies, including Meta, Alphabet, Nvidia and Microsoft.

Cash runway extended through 2026, beyond September 30, 2026 sunset date for rare pediatric priority review voucher (PRV) program Additional funding allows Company to advance strategic alternatives for OS Animal Health, close out OST-504 (previously ADXS-504) prostate cancer study and initiate AI-driven next-gen tADC product candidate modeling New York, New York--(Newsfile Corp. - July 14, 2025) - OS Therapies (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that it has closed its previously announced warrant exercise inducement and exchange offer. The Company raised a total of $4.2 million in gross proceeds from the offering.

Skydance Media CEO David Ellison has held preliminary talks to acquire The Free Press, an online news outlet, the New York Times reported on Friday, citing people familiar with the matter.

Key Points Inflation and loss of buying power is one of the greatest concerns among retirees living on fixed incomes. ETFs combinations that can deliver income, protect against inflation, and show upside appreciation is a win-win package that most investors will welcome. WisdomTree’s ETF menu can also offer strong dividend income, capital appreciation, and inflation protection via precious metals among its selections. Are you ahead or behind on retirement? Are you intimidated by your lack of investment knowledge when it comes to your portfolio? SmartAsset’s free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted and must act in your best interests. Don’t waste another minute – get started by clicking here.(Sponsor) According to the Senior Citizens League, loss of buying power is the #1 concern facing retirees in the US, with 92% listing it among their greatest fears in a recent survey. When retirees are l

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

-- Leading cannabis companies partner to leverage existing IP and brand value in New York -- CHICAGO and MINNEAPOLIS, July 01, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), a multi-state, vertically-integrated cannabis operator, is pleased to announce a licensing agreement with Curio Wellness (“Curio”), a cGMP-certified, vertically-integrated cannabis company and market-leading innovator of health and wellness products. This strategic partnership will bring Curio's celebrated Best Self Collection to the rapidly growing New York cannabis market.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.